
Janine Muir Kreck
Examiner (ID: 132)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3673, 3672 |
| Total Applications | 2379 |
| Issued Applications | 1776 |
| Pending Applications | 171 |
| Abandoned Applications | 455 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 2967611
[patent_doc_number] => 05274300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-28
[patent_title] => 'Enzymatic hydrolysis of glycidate esters in the presence of bisulfite anion'
[patent_app_type] => 1
[patent_app_number] => 7/309769
[patent_app_country] => US
[patent_app_date] => 1989-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19428
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 46
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/274/05274300.pdf
[firstpage_image] =>[orig_patent_app_number] => 309769
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/309769 | Enzymatic hydrolysis of glycidate esters in the presence of bisulfite anion | Feb 9, 1989 | Issued |
Array
(
[id] => 2644556
[patent_doc_number] => 04980291
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-12-25
[patent_title] => 'Process for the enzymatic separation of the optical isomers of racemic .alpha.-alkyl-substituted primary alcohols'
[patent_app_type] => 1
[patent_app_number] => 7/307913
[patent_app_country] => US
[patent_app_date] => 1989-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2770
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/980/04980291.pdf
[firstpage_image] =>[orig_patent_app_number] => 307913
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/307913 | Process for the enzymatic separation of the optical isomers of racemic .alpha.-alkyl-substituted primary alcohols | Feb 8, 1989 | Issued |
Array
(
[id] => 2704686
[patent_doc_number] => 05001052
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-03-19
[patent_title] => 'Immunoassay for FHAP and antibody useful therewith'
[patent_app_type] => 1
[patent_app_number] => 7/308238
[patent_app_country] => US
[patent_app_date] => 1989-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2386
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/001/05001052.pdf
[firstpage_image] =>[orig_patent_app_number] => 308238
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/308238 | Immunoassay for FHAP and antibody useful therewith | Feb 8, 1989 | Issued |
Array
(
[id] => 2630485
[patent_doc_number] => 04937182
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-06-26
[patent_title] => 'Method for predicting chemosensitivity of anti-cancer drugs'
[patent_app_type] => 1
[patent_app_number] => 7/307552
[patent_app_country] => US
[patent_app_date] => 1989-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4349
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/937/04937182.pdf
[firstpage_image] =>[orig_patent_app_number] => 307552
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/307552 | Method for predicting chemosensitivity of anti-cancer drugs | Feb 6, 1989 | Issued |
Array
(
[id] => 2664360
[patent_doc_number] => 04954264
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-09-04
[patent_title] => 'Apparatus for separating mononuclear cells from blood and method of manufacturing and using the same'
[patent_app_type] => 1
[patent_app_number] => 7/305953
[patent_app_country] => US
[patent_app_date] => 1989-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 4487
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/954/04954264.pdf
[firstpage_image] =>[orig_patent_app_number] => 305953
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/305953 | Apparatus for separating mononuclear cells from blood and method of manufacturing and using the same | Feb 1, 1989 | Issued |
Array
(
[id] => 2936185
[patent_doc_number] => 05190858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-03-02
[patent_title] => 'Monoclonal antibodies directed to epitopes of human transforming growth factor--.alpha. and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 7/304947
[patent_app_country] => US
[patent_app_date] => 1989-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9598
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/190/05190858.pdf
[firstpage_image] =>[orig_patent_app_number] => 304947
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/304947 | Monoclonal antibodies directed to epitopes of human transforming growth factor--.alpha. and uses thereof | Jan 31, 1989 | Issued |
Array
(
[id] => 2714022
[patent_doc_number] => 05008192
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-04-16
[patent_title] => 'Enzymatic process for the preparation of optically active cyanohydrins'
[patent_app_type] => 1
[patent_app_number] => 7/303336
[patent_app_country] => US
[patent_app_date] => 1989-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/008/05008192.pdf
[firstpage_image] =>[orig_patent_app_number] => 303336
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/303336 | Enzymatic process for the preparation of optically active cyanohydrins | Jan 29, 1989 | Issued |
Array
(
[id] => 2668656
[patent_doc_number] => 05034329
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-07-23
[patent_title] => 'Process for the preparation of optically active 2-arylalkanoic acids'
[patent_app_type] => 1
[patent_app_number] => 7/302193
[patent_app_country] => US
[patent_app_date] => 1989-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1595
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/034/05034329.pdf
[firstpage_image] =>[orig_patent_app_number] => 302193
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/302193 | Process for the preparation of optically active 2-arylalkanoic acids | Jan 26, 1989 | Issued |
| 07/302192 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 2-ARYLPROPIONIC ACIDS | Jan 26, 1989 | Abandoned |
Array
(
[id] => 2812641
[patent_doc_number] => 05079171
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-01-07
[patent_title] => 'Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin'
[patent_app_type] => 1
[patent_app_number] => 7/302854
[patent_app_country] => US
[patent_app_date] => 1989-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9180
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/079/05079171.pdf
[firstpage_image] =>[orig_patent_app_number] => 302854
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/302854 | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin | Jan 26, 1989 | Issued |
Array
(
[id] => 2692991
[patent_doc_number] => 04990443
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-02-05
[patent_title] => 'Hapten-protein conjugates and methods of use in immunoassays'
[patent_app_type] => 1
[patent_app_number] => 7/301582
[patent_app_country] => US
[patent_app_date] => 1989-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3839
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/990/04990443.pdf
[firstpage_image] =>[orig_patent_app_number] => 301582
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/301582 | Hapten-protein conjugates and methods of use in immunoassays | Jan 23, 1989 | Issued |
Array
(
[id] => 2528043
[patent_doc_number] => 04861867
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-08-29
[patent_title] => 'Purified hemoglobin solutions and method for making same'
[patent_app_type] => 1
[patent_app_number] => 7/280111
[patent_app_country] => US
[patent_app_date] => 1989-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9571
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/861/04861867.pdf
[firstpage_image] =>[orig_patent_app_number] => 280111
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/280111 | Purified hemoglobin solutions and method for making same | Jan 22, 1989 | Issued |
| 07/280112 | PURIFIED HEMOGLOBIN SOLUTIONS AND METHOD FOR MAKING SAME | Jan 22, 1989 | Abandoned |
Array
(
[id] => 2657508
[patent_doc_number] => 04978613
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-12-18
[patent_title] => 'Beta-lactamase assay employing chromogenic precipitating substrates'
[patent_app_type] => 1
[patent_app_number] => 7/298098
[patent_app_country] => US
[patent_app_date] => 1989-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5622
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/978/04978613.pdf
[firstpage_image] =>[orig_patent_app_number] => 298098
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/298098 | Beta-lactamase assay employing chromogenic precipitating substrates | Jan 16, 1989 | Issued |
Array
(
[id] => 2703658
[patent_doc_number] => 05068198
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-11-26
[patent_title] => 'Liquid single reagent for assays involving confining gels'
[patent_app_type] => 1
[patent_app_number] => 7/298192
[patent_app_country] => US
[patent_app_date] => 1989-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8780
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/068/05068198.pdf
[firstpage_image] =>[orig_patent_app_number] => 298192
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/298192 | Liquid single reagent for assays involving confining gels | Jan 12, 1989 | Issued |
Array
(
[id] => 2712151
[patent_doc_number] => 05009994
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-04-23
[patent_title] => 'Particles containing mannitol suitable for tabletting into diagnostic reagents'
[patent_app_type] => 1
[patent_app_number] => 7/296178
[patent_app_country] => US
[patent_app_date] => 1989-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5576
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/009/05009994.pdf
[firstpage_image] =>[orig_patent_app_number] => 296178
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/296178 | Particles containing mannitol suitable for tabletting into diagnostic reagents | Jan 11, 1989 | Issued |
Array
(
[id] => 2730436
[patent_doc_number] => 05039521
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-08-13
[patent_title] => 'Immune cell proliferation inhibitors'
[patent_app_type] => 1
[patent_app_number] => 7/295734
[patent_app_country] => US
[patent_app_date] => 1989-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4802
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/039/05039521.pdf
[firstpage_image] =>[orig_patent_app_number] => 295734
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/295734 | Immune cell proliferation inhibitors | Jan 10, 1989 | Issued |
Array
(
[id] => 2629570
[patent_doc_number] => 04957742
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-09-18
[patent_title] => 'Method for promoting hair growth'
[patent_app_type] => 1
[patent_app_number] => 7/295406
[patent_app_country] => US
[patent_app_date] => 1989-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2492
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/957/04957742.pdf
[firstpage_image] =>[orig_patent_app_number] => 295406
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/295406 | Method for promoting hair growth | Jan 9, 1989 | Issued |
Array
(
[id] => 3026560
[patent_doc_number] => 05316911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-31
[patent_title] => 'Method of determining the presence of endotoxin in a sample'
[patent_app_type] => 1
[patent_app_number] => 7/295213
[patent_app_country] => US
[patent_app_date] => 1989-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14734
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/316/05316911.pdf
[firstpage_image] =>[orig_patent_app_number] => 295213
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/295213 | Method of determining the presence of endotoxin in a sample | Jan 5, 1989 | Issued |
Array
(
[id] => 2667161
[patent_doc_number] => 04904641
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-02-27
[patent_title] => 'Method of inactivating reproducible filterable pathogens in blood plasma products'
[patent_app_type] => 1
[patent_app_number] => 7/293085
[patent_app_country] => US
[patent_app_date] => 1989-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5348
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/904/04904641.pdf
[firstpage_image] =>[orig_patent_app_number] => 293085
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/293085 | Method of inactivating reproducible filterable pathogens in blood plasma products | Jan 2, 1989 | Issued |